Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel epoxidation reagent replacing toxic dimethyl sulfide. Recyclable, water-soluble, high yield. Reliable supplier for pharmaceutical intermediates.
Novel route for Siponimod avoids hazardous diazotization and chromatography, offering cost reduction in API manufacturing and enhanced supply chain reliability for global partners.
Patent CN102229537B reveals a one-pot synthesis for Diphenhydramine Citrate, offering significant cost reduction and streamlined supply chain for API manufacturing.
Novel synthesis method for anti-HIV active derivatives offering stable quality and scalable production for pharmaceutical intermediates ensuring supply chain reliability.
Novel ruthenium catalyst recovery method for adamantane polyol manufacturing ensuring cost efficiency and supply chain stability for global buyers.
Patent CN101575293A reveals a safer route for iodobenzene diacetate using sodium perborate, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN104876994B details advanced RP-HPLC purification for oxidized NADH. Achieves superior purity and yield, offering significant supply chain and cost advantages for pharmaceutical manufacturers.
Novel method using sodium perborate for iodobenzene diacetate. Safer, scalable process replacing hazardous peracetic acid for reliable supply chain.
Novel patent CN117105977A enables mild synthesis. Reduces costs and improves supply chain reliability for high-purity intermediates.
Advanced purification method for 2'-fluoro-2'-deoxyuridine via esterification. Delivers >98.5% purity for reliable pharmaceutical intermediate supply chains.
Patent CN116396330A discloses a stable synthesis route for CRAC inhibitors, offering improved purity and scalable manufacturing for pharmaceutical intermediates.
Novel synthesis patent CN107417810B offers high-purity anti-HIV intermediates with scalable processes for reliable pharmaceutical supply chains and cost-effective manufacturing solutions globally.
Electrochemical carboxylation patent CN108560016A enables high-purity pharmaceutical intermediate manufacturing with reduced environmental impact and scalable supply chain reliability for global buyers.
Patent CN110914417B reveals high-activity transaminase for chiral amine synthesis, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN106831606B reveals a high-yield route for 5-trifluoromethyl-5,6-dihydrouracil. Discover cost-effective manufacturing and reliable supply chain solutions.
Patent CN103214455A reveals a mild hypochlorite oxidation route for Bilastine, offering high yield and purity for reliable pharmaceutical intermediate supply chains.
Novel patent CN114656401A details cost-effective Sorafenib intermediate production with high purity and scalable chlorination methods for global supply chains.
Patent CN115010654A reveals acid-free 2 2'-bipyridine synthesis ensuring high purity and reduced environmental impact for pharmaceutical intermediate supply chains.
Patent CN100497311C details a high-yield aminolysis process for 2-amino-3-chloro-5-trifluoromethylpyridine, offering superior purity and reduced environmental impact for agrochemical supply chains.
Patent CN105198690B details Pd-catalyzed fluorene synthesis. Offers cost reduction and supply reliability for optoelectronic material manufacturing.